Infinion Biopharma files draft papers with SEBI for IPO

03 Sep 2021 Evaluate

Infinion Biopharma has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) for an Initial Public Offering (IPO). The IPO comprises the sale of 45 lakh equity shares of Infinion Biopharma.

Proceeds from the IPO will be used towards investment in Mobius Biomedical Inc, acquisition of licenses for product development of skincare and women's health products and working capital requirements. In addition, funds will be used for sales, marketing and distribution expenses for setting up the company's geographical reach and for general corporate purposes. Aryaman Financial Services is the sole book-running lead manager to the issue.

Infinion Biopharma is an innovation-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas.

Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...